Retatrutide beneficial as a monotherapy in adults with T2D inadequately controlled with diet and exercise alone.
The FDA linked 12 severe kidney complications to alli between 2007 and 2023, resulting in 8 hospitalizations and 5 patients requiring dialysis. The Food and Drug Administration (FDA) has updated the ...
The update now allows for a maintenance dosage of 250mg once every 8 weeks in adults and children aged 12 years and older weighing at least 40kg. The Food and Drug Administration (FDA) has approved a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results